Haleon (HLN) FCF Margin (2021 - 2023)
Haleon (HLN) recorded quarterly FCF Margin of 4.36% in Q4 2023, up 46.85% on a QoQ basis from 2.97% in Q4 2022, and up 139.0% year-over-year from 1.82% in Q4 2022.
Haleon (HLN) FCF Margin (2021 - 2023) Analysis & Trends
Haleon has disclosed FCF Margin across 3 years of filings, most recently posting 4.36% for Q4 2023.
- Quarterly FCF Margin rose 139.0% year-over-year to 4.36% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 1.78% (changed N/A YoY) and the FY2025 annual result came in at 20.96%, up 270.0% from the prior year.
- FCF Margin rose to 4.36% in Q4 2023, from 2.97% in the prior quarter.
- Over five years, FCF Margin peaked at 4.36% in Q4 2023 and troughed at 2.97% in Q4 2022.
- A 3-year average of 3.63% and a median of 3.57% in 2021 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 61 bps — and 2023, when it soared 139 bps.
- Tracing HLN's FCF Margin over 3 years: stood at 3.57% in 2021, then slipped by 17 bps to 2.97% in 2022, then jumped by 47 bps to 4.36% in 2023.
- Business Quant data shows HLN's FCF Margin at 4.36% in Q4 2023, 2.97% in Q4 2022, and 3.57% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Haleon | 1.09 Bn | -773.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.36% |
| Dec 31, 2022 | 2.97% |
| Dec 31, 2021 | 3.57% |